Albemarle (ALB) to Release Earnings on Wednesday

by · The Cerbat Gem

Albemarle (NYSE:ALB – Get Free Report) is expected to release its Q4 2025 results after the market closes on Wednesday, February 11th. Analysts expect the company to announce earnings of ($0.62) per share and revenue of $1.3410 billion for the quarter. Individuals may review the information on the company’s upcoming Q4 2025 earning report for the latest details on the call scheduled for Thursday, February 12, 2026 at 8:00 AM ET.

Albemarle Stock Up 4.5%

ALB opened at $163.47 on Monday. The company has a debt-to-equity ratio of 0.40, a current ratio of 2.27 and a quick ratio of 1.51. The company’s 50-day moving average is $154.02 and its 200 day moving average is $112.49. Albemarle has a fifty-two week low of $49.43 and a fifty-two week high of $195.68. The firm has a market capitalization of $19.24 billion, a P/E ratio of -102.81, a PEG ratio of 2.92 and a beta of 1.44.

Wall Street Analyst Weigh In

ALB has been the topic of several recent analyst reports. Argus lifted their target price on shares of Albemarle from $120.00 to $140.00 and gave the stock a “buy” rating in a research report on Monday, November 17th. Stephens reiterated an “outperform” rating on shares of Albemarle in a report on Friday, December 19th. UBS Group upped their price objective on Albemarle from $185.00 to $205.00 and gave the company a “buy” rating in a research note on Monday, January 12th. Morgan Stanley reaffirmed an “equal weight” rating on shares of Albemarle in a research report on Friday, December 19th. Finally, Evercore boosted their price target on shares of Albemarle from $88.00 to $100.00 and gave the stock an “in-line” rating in a report on Tuesday, November 11th. Three research analysts have rated the stock with a Strong Buy rating, twelve have issued a Buy rating, eleven have assigned a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $161.16.

Read Our Latest Research Report on ALB

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the stock. CIBC Bancorp USA Inc. purchased a new stake in shares of Albemarle in the third quarter worth about $5,482,000. Coldstream Capital Management Inc. bought a new stake in Albemarle during the 3rd quarter worth approximately $318,000. Danske Bank A S purchased a new stake in Albemarle in the 3rd quarter worth approximately $154,000. Eaton Financial Holdings Company LLC boosted its holdings in Albemarle by 64.9% in the 3rd quarter. Eaton Financial Holdings Company LLC now owns 5,703 shares of the specialty chemicals company’s stock valued at $462,000 after purchasing an additional 2,245 shares during the period. Finally, Greenline Partners LLC grew its position in shares of Albemarle by 22.5% during the 3rd quarter. Greenline Partners LLC now owns 65,258 shares of the specialty chemicals company’s stock valued at $5,291,000 after purchasing an additional 11,967 shares in the last quarter. Institutional investors own 92.87% of the company’s stock.

Albemarle Company Profile

(Get Free Report)

Albemarle Corporation is a leading global specialty chemicals company primarily engaged in the production and distribution of lithium, bromine, and catalysts. Its lithium segment supplies key components used in rechargeable batteries for electric vehicles, portable electronics, and grid storage systems. The company’s bromine specialty products serve a wide range of industries, including oil and gas drilling fluids, fire safety solutions, and water treatment. In its catalysts division, Albemarle provides products for petroleum refining, chemical processing and emissions control.

Founded in 1994 as a spin-off from Ethyl Corporation, Albemarle has grown through strategic acquisitions and capacity expansions to become one of the world’s foremost chemical producers.

Further Reading